| Record ID | marc_loc_2016/BooksAll.2016.part37.utf8:113586142:1464 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part37.utf8:113586142:1464?format=raw |
LEADER: 01464cam a22003854a 4500
001 2010002978
003 DLC
005 20110125082636.0
008 100122s2010 nyuab b 001 0 eng
010 $a 2010002978
015 $aGBB037612$2bnb
016 7 $a101523299$2DNLM
016 7 $a015505919$2Uk
020 $a9781616682330 (softcover)
020 $a1616682337 (softcover)
035 $a(OCoLC)ocn502393287
040 $aDNLM/DLC$cDLC$dYDX$dNLM$dUKM$dYDXCP$dDLC
042 $apcc
050 00 $aRM409$b.V56 2010
060 10 $aWF 360$bV788d 2010
082 00 $a615.5/8$222
100 1 $aVinšová, Jarmila.
245 10 $aDevelopment of new MDR-tuberculosis drugs /$cJarmila Vinšová and Martin Krátký.
260 $aNew York :$bNova Science Publisher/Nova Biomedical,$cc2010.
300 $axii, 98 p. :$bill., col. map ;$c23 cm.
490 1 $aPharmacology - research, safety testing and regulation
504 $aIncludes bibliographical references and index.
505 0 $aResistance to commonly used drugs, mechanism of the action -- Research of novel MDR potential drugs.
650 0 $aAntitubercular agents.
650 0 $aMultidrug-resistant tuberculosis$xChemotherapy.
650 12 $aTuberculosis, Multidrug-Resistant$xdrug therapy.
650 22 $aDrug Discovery.
650 22 $aDrug Resistance, Multiple$xdrug effects.
700 1 $aKrátký, Martin,$d1960-
830 0 $aPharmacology-research, safety testing, and regulation series.